Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dantrolene 833micrograms/5ml oral liquid
1002020J0AABNBN
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 8mg/5ml oral liquid
1002020J0AABGBG
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 90mg/5ml oral liquid
1002020J0AABJBJ
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 9mg/5ml oral liquid
1002020J0AABABA
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Daonil 5mg tablets
0601021H0BBAAAB
|
Daonil | Glibenclamide | Endocrine System | No data available |
|
Dapsone 100mg / Pyrimethamine 12.5mg tablets
0504010Q0AAAAAA
|
Pyrimethamine/dapsone | Pyrimethamine with dapsone | Infections | No data available |
|
Dapsone 20mg/5ml oral suspension
0501100H0AAAPAP
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 40mg/5ml oral suspension
0501100H0AAAMAM
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 50mg/5ml oral suspension
0501100H0AAALAL
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 5mg/5ml oral liquid
0501100H0AAAKAK
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 75mg/5ml oral suspension
0501100H0AAANAN
|
Dapsone | Dapsone | Infections | No data available |
|
Daptomycin 350mg powder for solution for infusion vials
0501070Y0AAAAAA
|
Daptomycin | Daptomycin | Infections | No data available |
|
Daptomycin 500mg powder for solution for infusion vials
0501070Y0AAABAB
|
Daptomycin | Daptomycin | Infections | No data available |
|
Darbepoetin alfa 130micrograms/0.65ml inj pf dispos dev
0901030J0AAAWAW
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Darbepoetin alfa 15micrograms/0.375ml inj pfs
0901030J0AAADAD
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Darmil 100mg tablets
0203020D0BEAAAA
|
Darmil | Amiodarone hydrochloride | Cardiovascular System | No data available |
|
Darmil 200mg tablets
0203020D0BEABAB
|
Darmil | Amiodarone hydrochloride | Cardiovascular System | No data available |
|
Darunavir 100mg/ml oral suspension sugar free
0503010ACAAAFAF
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 150mg tablets
0503010ACAAAEAE
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 300mg tablets
0503010ACAAAAAA
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 600mg tablets
0503010ACAAACAC
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 75mg tablets
0503010ACAAADAD
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 800mg / Cobicistat 150mg tablets
0503010AKAAAAAA
|
Darunavir/cobicistat | Darunavir/cobicistat | Infections | No data available |
|
Dasabuvir 250mg tablets
0503032H0AAAAAA
|
Dasabuvir | Dasabuvir | Infections | No data available |
|
Dasatinib 100mg tablets
0801050ANAAADAD
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.